Publication date: Aug 24, 2024
To understand how health, education and social care services for disabled children changed during the COVID-19 pandemic, what did or did not work well and what the impacts of service changes were on both professionals and families. Qualitative study using semistructured interviews. Telephone and video call interviews and focus groups with professionals working in one of five local authority areas in England. 78 health, education and social care professionals working with children in one of five local authority areas in England. There was a significant disruption to services and reduced contact with families during the early stages of the pandemic; nevertheless, professionals were able to reflect on innovative ways they interacted with and sought to support and maintain health, education and social care provision to disabled children and their families. As waitlists have substantially increased, this and the longevity of the pandemic were perceived to have had negative consequences for staff health and well-being, the health and psychosocial outcomes of children and young people, and their parent carers. Key learning from this study for service recovery and planning for future emergencies is the need to be able to identify disabled children, classify their level of need and risk, assess the impact of loss of services and maintain clear communication across services to meet the needs of disabled children. Finally, services need to work collaboratively with families to develop child-centred care to strengthen resilience during service disruption.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | quality |
disease | MESH | COVID-19 pandemic |
drug | DRUGBANK | Etoperidone |
disease | MESH | emergencies |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Trestolone |
disease | VO | effective |
disease | IDO | process |
disease | MESH | Epilepsy |
disease | VO | time |
disease | MESH | infection |
drug | DRUGBANK | Gold |
drug | DRUGBANK | Silver |
drug | DRUGBANK | Methionine |
disease | MESH | dissociative seizures |
disease | MESH | non epileptic seizures |
disease | VO | Gap |
disease | VO | vaccination |
disease | IDO | history |
disease | MESH | autism |
disease | MESH | Attention Deficit Hyperactivity Disorder |
disease | IDO | country |
disease | IDO | intervention |
disease | MESH | burnout |
disease | MESH | contractures |
drug | DRUGBANK | Spinosad |
drug | DRUGBANK | Serine |
disease | VO | monthly |
disease | VO | population |
pathway | REACTOME | Translation |
disease | VO | report |
disease | MESH | intellectual disabilities |
disease | VO | efficient |
disease | MESH | developmental disabilities |
disease | MESH | moral injury |